Groupama Asset Managment Makes New Investment in Cencora, Inc. $COR

Groupama Asset Managment bought a new stake in Cencora, Inc. (NYSE:COR) during the 3rd quarter, Holdings Channel reports. The firm bought 3,919 shares of the company’s stock, valued at approximately $1,225,000.

A number of other institutional investors have also modified their holdings of the stock. IAG Wealth Partners LLC acquired a new stake in shares of Cencora during the third quarter worth $30,000. Cloud Capital Management LLC purchased a new position in Cencora in the 3rd quarter valued at $31,000. Caitlin John LLC acquired a new position in Cencora in the 3rd quarter valued at $31,000. Vermillion & White Wealth Management Group LLC increased its stake in Cencora by 69.4% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after buying an additional 43 shares during the period. Finally, Westside Investment Management Inc. raised its position in Cencora by 200.0% during the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock worth $33,000 after buying an additional 70 shares during the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Activity

In other news, CEO Robert P. Mauch sold 5,096 shares of the business’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the sale, the chief executive officer owned 66,726 shares of the company’s stock, valued at $23,669,713.98. The trade was a 7.10% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on COR shares. Barclays raised their target price on shares of Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. Weiss Ratings raised shares of Cencora from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, February 5th. Wells Fargo & Company raised their price objective on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. JPMorgan Chase & Co. lifted their price objective on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Finally, Morgan Stanley set a $380.00 target price on Cencora in a research report on Tuesday. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Cencora has an average rating of “Moderate Buy” and an average target price of $403.17.

Cencora Stock Performance

NYSE:COR opened at $327.96 on Friday. The firm’s fifty day simple moving average is $354.93 and its 200-day simple moving average is $339.61. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The stock has a market cap of $63.80 billion, a PE ratio of 39.42, a price-to-earnings-growth ratio of 1.55 and a beta of 0.68. Cencora, Inc. has a fifty-two week low of $265.59 and a fifty-two week high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, beating the consensus estimate of $4.04 by $0.04. The firm had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter last year, the business earned $3.73 earnings per share. Analysts expect that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is presently 28.85%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.